Department of Otorhinolaryngology/Head and Neck Surgery.
Department of Neurosurgery.
Otol Neurotol. 2021 Mar 1;42(3):475-482. doi: 10.1097/MAO.0000000000002980.
To identify predictors of tumor recurrence and postoperative facial nerve function after translabyrinthine surgery for unilateral vestibular schwannomas.
Retrospective study.
Tertiary referral center.
Between 1996 and 2017 a total of 596 patients with unilateral vestibular schwannoma underwent translabyrinthine surgery. Pre- and postoperative clinical status, radiological, and surgical findings were evaluated.
Translabyrinthine surgery.
Potential predictors for tumor recurrence and facial nerve outcome were analyzed using Cox regression and ordinal logistic regression, respectively.
The extent of tumor removal was total in 32%, near-total in 58%, and subtotal in 10%. In 5.5% (33/596) of patients the tumor recurred. Subtotal tumor resection (p = 0.004, hazard ratios [HR] = 10.66), a young age (p = 0.008, HR = 0.96), and tumor progression preoperatively (p = 0.042, HR = 2.32) significantly increased the risk of recurrence, whereas tumor size or histologic composition did not. A good postoperative facial nerve function (House-Brackmann grade 1-2) was achieved in 85%. The risk of postoperative facial nerve paresis or paralysis increased with tumor size (p < 0.001, OR = 1.52), but was not associated with the extent of tumor removal, histologic composition, or patient demographics.
Translabyrinthine surgery is an effective treatment for vestibular schwannoma, with a good local control rate and facial nerve outcome. The extent of tumor removal is a clinically relevant predictor for tumor recurrence, as are young patient age and preoperative tumor progression. A large preoperative tumor size is associated with a higher risk of postoperative facial nerve paresis or paralysis.
确定单侧前庭神经鞘瘤经迷路手术后肿瘤复发和术后面神经功能的预测因素。
回顾性研究。
三级转诊中心。
1996 年至 2017 年期间,共有 596 例单侧前庭神经鞘瘤患者接受经迷路手术。评估了术前和术后的临床状况、影像学和手术发现。
经迷路手术。
使用 Cox 回归和有序逻辑回归分别分析肿瘤复发和面神经结果的潜在预测因素。
肿瘤切除程度完全为 32%,近全切除为 58%,次全切除为 10%。5.5%(33/596)的患者肿瘤复发。次全肿瘤切除(p=0.004,风险比[HR]=10.66)、年龄较小(p=0.008,HR=0.96)和术前肿瘤进展(p=0.042,HR=2.32)显著增加了复发风险,而肿瘤大小或组织学组成则没有。术后面神经功能良好(House-Brackmann 分级 1-2)达 85%。术后面神经瘫痪或麻痹的风险随肿瘤大小增加(p<0.001,OR=1.52),但与肿瘤切除程度、组织学组成或患者人口统计学无关。
经迷路手术是治疗前庭神经鞘瘤的有效方法,具有良好的局部控制率和面神经结果。肿瘤切除程度是肿瘤复发的一个具有临床意义的预测因素,年轻患者年龄和术前肿瘤进展也是如此。术前肿瘤较大与术后面神经瘫痪或麻痹的风险增加相关。